PP2Calpha, Active(P02-20G)

PP2Calpha, Active(P02-20G)

  • $226.00


Description :Recombinant full-length human PP2Calpha was expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag.

Species :Human

Tag :GST tag

Expression System:Sf9 insect cells using baculovirus

Sequence :Full Length

Genbank Number :NM_021003

Specific Activity :Sample Enzyme Activity Plot. For specific information on a given lot, see related technical data sheet.

Purity :Sample Purity Data. For specific information on a given lot, see related technical data sheet.

Storage, Stability and Shipping :Store product at –70oC. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles.

Applications :Phosphatase Assay, Western Blot

Molecular Weight :~105 kDa

Gene Aliases :PP2C-ALPHA, PPM1A, PP2CA, MGC9201, FLJ42306

Scientific Background :PP2Cα is a member of the family of Ser/Thr protein phosphatases and is composed of a catalytic subunit and a constant regulatory subunit. PP2C alpha is known to be negative regulators of cell stress response pathways. PP2C alpha has been reported to negatively regulate TGFβ signaling pathway and cell cycle. PP2C alpha has been shown to dephosphorylate cyclin-dependent kinases (CDKs) and it may be involved in cell cycle control (1). Overexpression of PP2C alpha is reported to cause cell-growth arrest or cell death. PP2C alpha is highly expressed in heart and skeletal muscle (2).

References :
1. Parvari, R. et. al: A recessive contiguous gene deletion of chromosome 2p16 associated with cystinuria and a mitochondrial disease. Am. J. Hum. Genet. 69: 869-875, 2001.

2. Marley, A. E. et. al: The cloning expression and tissue distribution of human PP2C-beta.FEBS Lett. 431: 121-124, 1998.

Product Sheets (By Lot #) :



Research Areas :Cancer, Cardiovascular Disease, Cell Cycle, ERK/MAPK Pathway, Metabolic Disorder, Phosphatases, Ser/Thr Kinases, Cancer, Metabolic Disorder, Cardiovascular Disease, ERK/MAPK Pathway, Cell Cycle, Ser/Thr Kinases, Phosphatases